CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel platform for assessing drug-induced tissue damage and the immune response, addressing a critical gap in preclinical toxicity testing. The platform, PHIVIDIAS, aims to provide comprehensive and animal-free evaluations.
Drug-induced tissue damage and the associated risk for developing auto-immune secondary disease is fully ignored in preclinical toxicity testing.
As a consequence, there are currently 300 drugs on the market that cause drug-induced auto-immune-mediated interstitial lung disease.
In their regulatory documents, EMA and FDA strongly advocate for inclusion of tests to address this type of adverse effects in preclinical research.
Immundz (www.immundnz.com) addresses this market opportunity by develop…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
